Serotonin and Noradrenaline Reuptake Inhibitors: all 504 studies that test it
Page 5 of 6. Open to participants first (35), then studies with results posted, then the rest; newest registration first within each.
- Study Evaluating Effexor® (Venlafaxine) in Achieving Response and Maintaining RemissionCompletedNCT00546494Phase 4
- Duloxetine - Warfarin Pharmacodynamic StudyCompletedNCT00533026Phase 1
- An Open Trial of Duloxetine on Comorbid Major Depression and Chronic HeadacheCompletedNCT00531895Phase 4
- Duloxetine for Perimenopausal DepressionCompletedNCT00517985Phase 4
- Duloxetine Versus Duloxetine Plus Non-Drug Therapy for DepressionCompletedNCT00494377Phase 4
- Effects of Duloxetine on Pathological Worry in Patients With Generalized Anxiety Disorder: A fMRI StudyTerminatedNCT00491348Not applicable
- Duloxetine Versus Paroxetine for Major DepressionCompletedNCT00489775Phase 3
- Duloxetine Versus Placebo for FibromyalgiaCompletedNCT00489073Phase 3
- Lilly's Emotional and Physical Symptoms of Depression Study (LEAPS)CompletedNCT00479726Phase 4
- Duloxetine vs Placebo in the Treatment of General AnxietyCompletedNCT00475969Phase 3
- Urge Incontinence Bladder Overactivity StudyCompletedNCT00475696Phase 2
- Duloxetine Stress Urinary Incontinence Efficacy and Safety StudyCompletedNCT00475397Phase 3
- Efficacy and Safety Stress Urinary Incontinence StudyCompletedNCT00475358Phase 3
- Study Evaluating DVS-233 for Treatment of Outpatients With Major Depressive DisorderCompletedNCT00452595Phase 3
- A Multicentre Trial to Determine the Efficacy and Safety of Milnacipran in the Treatment of Fibromyalgia SyndromeCompletedNCT00436033Phase 3
- Open Label Study of Duloxetine for the Treatment of Phantom Limb PainTerminatedNCT00425230Not applicable
- Study Evaluating the Safety & Efficacy of DVS-223 SR for Relief of Vasomotor Symptoms Associated With MenopauseCompletedNCT00421031Phase 3
- Evaluation of the Effects of Duloxetine on NorepinephrineCompletedNCT00414323Phase 1
- Treatment With Duloxetine for OCD PatientsWithdrawnNCT00399022Not applicable
- A Study Of GSK189254 And Duloxetine In The Electrical Hyperalgesia Model Of Healthy VolunteersCompletedNCT00387413Phase 1
- Effects of Pregabalin, Duloxetine & Amitriptyline on Pain & SleepCompletedNCT00370656Phase 2/3
- Study of the Safety and Efficacy of Desvenlafaxine Succinate for Vasomotor Symptoms in Postmenopausal WomenCompletedNCT00369434Phase 3
- Study Evaluating the Effects of DVS SR and Duloxetine on the Pharmacokinetics of Desipramine in Healthy SubjectsCompletedNCT00366652Phase 3
- Study Evaluating the Pharmacokinetics of Venlafaxine ER and Desvenlafaxine SR in Healthy SubjectsCompletedNCT00329186Phase 3
- Study Evaluating the Efficacy of DVS-233 in FibromyalgiaTerminatedNCT00301431Phase 2/3
- Study Evaluating the Efficacy and Safety of Desvenlafaxine Tablets in Adult Outpatients With Major Depressive DisorderCompletedNCT00300378Phase 3
- A Pilot Study Assessing Duloxetine's Efficacy in Atypical DepressionCompletedNCT00296699Phase 4
- Tolerability of Switching to Duloxetine for the Management of Diabetic Nerve PainCompletedNCT00266643Phase 4
- Study Evaluating DVS-233 SR to Treat Vasomotor Systems Associated With MenopauseCompletedNCT00256685Phase 3
- Effectiveness of Nefazodone and Bupropion in Treating Marijuana Dependent IndividualsCompletedNCT00249509Phase 2
- Venlafaxine to Reduce Cocaine Dependence in Depressed IndividualsCompletedNCT00249483Phase 2
- To Determine How Effective Duloxetine is in Treating Women 65 Years and Older With Symptoms of Stress Urinary Incontinence, or With a Combination of Stress Urinary Incontinence and Urge Urinary Incontinence SymptomsCompletedNCT00244296Phase 4
- Study Evaluating DVS-233 SR in Elderly Outpatients With Major Depressive DisorderCompletedNCT00242229Not applicable
- Study Evaluating Venlafaxine ER in Children and Adolescents With Social Anxiety DisorderCompletedNCT00238719Phase 3
- Duloxetine Versus Placebo in the Treatment of FMSCompletedNCT00233025Phase 3
- Nefazodone in the Treatment of Social PhobiaCompletedNCT00231348Phase 4
- Study Evaluating Long-Term Safety of Effexor XR in Patients With Major Depression.CompletedNCT00225524Phase 3
- Study Evaluating Effexor XR for Major Depression.CompletedNCT00225511Phase 3
- Study Evaluating Effexor XR in Elderly Patients With Major Depression.CompletedNCT00225485Phase 3
- Treatment of MDEs During the Course of Psychotic Disorders With DuloxetineCompletedNCT00224302Phase 4
- Pharmacological Intervention in Depression After Traumatic Brain InjuryCompletedNCT00205491Phase 4
- Venlafaxine for Hot Flashes After Breast CancerCompletedNCT00198250Phase 2
- Study Comparing Venlafaxine vs. Paroxetine in Panic DisorderCompletedNCT00195598Phase 3
- Study Evaluating DVS-233 SR for Treatment of Vasomotor Symptoms Associated With MenopauseCompletedNCT00195546Phase 3
- Switching to Duloxetine From Other AntidepressantsCompletedNCT00191932Phase 4
- A Randomized Double Blind Study Evaluating Duloxetine in Outpatients With MDD and PainCompletedNCT00191919Phase 3
- Duloxetine in the Treatment of Melancholic DepressionCompletedNCT00191685Phase 3
- Open-Label Duloxetine Extension Phase in Patients Who Have Completed Previous Duloxetine TrialsCompletedNCT00191594Phase 3
- Open Label Phase III Duloxetine Study for Stress Urinary IncontinenceCompletedNCT00191204Phase 3
- Duloxetine in the Treatment of Stress Urinary Incontinence.CompletedNCT00191087Phase 3
- A Comparison of Tolerability and Efficacy of Different Doses of Duloxetine for the Treatment of Major Depressive DisorderCompletedNCT00191061Phase 4
- Evaluate Safety and Efficacy of Duloxetine in Predominant Stress Urinary IncontinenceCompletedNCT00190996Phase 3
- Safety and Effectiveness Study of Duloxetine HCl in Women of Different Backgrounds With Stress Urinary Incontinence Who May Also Have Other Various Medical Conditions.CompletedNCT00190905Phase 4
- Study of Duloxetine Versus Placebo in the Treatment of Fibromyalgia SyndromeCompletedNCT00190866Phase 3
- Biomechanical and Electrophysiological Effects of Duloxetine in the Treatment of Women With Urinary Stress IncontinenceCompletedNCT00190853Phase 3
- Effectiveness of Duloxetine in the Treatment of Stress Urinary Incontinence(Uncontrolled Leakage of Urine)CompletedNCT00190827Phase 3
- Effectiveness and Safety of Duloxetine in Women Experiencing Urinary Leakage Due to Physical Stress and Urge.CompletedNCT00190814Phase 3
- To Evaluate the Safety of Duloxetine in Patients With Stress Urinary IncontinenceCompletedNCT00190645Phase 3
- To Evaluate the Safety in Patients Taking Duloxetine for Stress Urinary IncontinenceCompletedNCT00190632Phase 3
- Efficacy and Safety of DuloxetineCompletedNCT00190619Phase 3
- Efficacy and Safety of Duloxetine, Placebo and Pelvic Floor Muscle Training in Subjects With Stress Urinary IncontinenceCompletedNCT00190606Phase 2
- Biomechanical Effects of Duloxetine on Bladder and Sphincter Muscle Function in Women in Pure Genuine Stress IncontinenceCompletedNCT00190567Phase 2
- Venlafaxine Versus Lamotrigine in the Treatment of Bipolar I/II DepressionCompletedNCT00188643Phase 4
- Does Concurrent Hydrocortisone With Venlafaxine XR Speed Antidepressant Response?CompletedNCT00186264Not applicable
- Duloxetine for the Treatment of DysthymiaCompletedNCT00185575Not applicable
- Sertraline vs. Venlafaxine XRCompletedNCT00179283Phase 3
- Effects of Venlafaxine on Chronic Neuropathic Pain Following Spinal Cord InjuryCompletedNCT00167856Not applicable
- Comparison of Pregabalin Versus Venlafaxine XR and Placebo in the Treatment of Generalized Anxiety DisorderCompletedNCT00151450Phase 3
- Hippocampal Volume in Young Patients With Major Depression Before and After Combined Antidepressive TherapyCompletedNCT00150839Phase 4
- A Study of Duloxetine in the Treatment of FibromyalgiaCompletedNCT00125892Phase 3
- Duloxetine Compared With Placebo in the Prevention of Relapse in Generalized Anxiety DisorderCompletedNCT00122863Phase 3
- A Comparison of Duloxetine Hydrochloride, Marketed Comparator, and Placebo in the Treatment of Generalized Anxiety DisorderCompletedNCT00122850Phase 3
- A Comparison of Duloxetine Hydrochloride, Marketed Comparator, and Placebo in the Treatment of Generalized Anxiety DisorderCompletedNCT00122837Phase 3
- Duloxetine Compared With Placebo in Patients With Generalized Anxiety DisorderCompletedNCT00122824Phase 3
- Serotonin Effect in Functional DyspepsiaCompletedNCT00115362Not applicable
- Study of Milnacipran for the Treatment of FibromyalgiaCompletedNCT00098124Phase 3
- Study Evaluating DVS-233 SR in Adult Outpatients With Major Depressive DisorderCompletedNCT00092911Phase 3
- Study Evaluating DVS-233 SR And Venlafaxine ER In Adult Outpatients With Major Depressive DisorderCompletedNCT00090649Phase 3
- Study Evaluating DVS-233 SR and Venlafaxine ER in Adult Outpatients With Major Depressive DisorderCompletedNCT00087737Phase 3
- Venlafaxine With or Without Zolpidem in Treating Hot Flashes and Associated Sleep Disorders in Women With Breast Cancer OR at High Risk for Developing Breast CancerCompletedNCT00084669Not applicable
- Study Evaluating DVS-233 SR In Adult Outpatients With Major Depressive DisorderCompletedNCT00075257Phase 3
- Study Evaluating DVS-233 SR In Adult Outpatients With Major Depressive DisorderCompletedNCT00073762Phase 3
- Duloxetine Compared to Escitalopram and Placebo in the Treatment of Patients With DepressionCompletedNCT00073411Phase 3
- Study Evaluating DVS-233 SR In Adult Outpatients With Major Depressive DisorderCompletedNCT00072774Phase 3
- Duloxetine vs. Active Comparator in the Treatment of Patients With DepressionCompletedNCT00071695Phase 4
- Duloxetine vs. Active Comparator for the Treatment of DepressionCompletedNCT00067912Phase 4
- Study Evaluating DVS-233 in Adult Outpatients With Major Depressive DisorderCompletedNCT00063206Phase 3
- Study of Duloxetine in Elderly Patients With Major Depressive DisorderCompletedNCT00062673Phase 3
- A Study for the Treatment of Painful Diabetic NeuropathyCompletedNCT00058968Phase 3
- Improving Retention of Hispanics Receiving Antidepressant TherapyCompletedNCT00057642Not applicable
- Study Evaluating Venlafaxine ER in Recurrent DepressionCompletedNCT00046020Phase 4
- Optimizing Electroconvulsive Therapy for DepressionCompletedNCT00045916Phase 4
- Study Evaluating Venlafaxine ER in Patients With Panic DisorderCompletedNCT00044772Phase 3
- Dose Escalation, Double-Blind Treatment With Duloxetine Hydrochloride Once Daily Dosing for Evaluation of Safety in Major DepressionCompletedNCT00042575Phase 3
- Open-Label Treatment With Duloxetine Hydrochloride Once-Daily Dosing for Evaluation of Stabilization Dose in Patients With Major DepressionCompletedNCT00042562Phase 3
- Study Evaluating Venlafaxine ER in Adults With Panic DisorderCompletedNCT00038896Phase 3
- Subject Information and Consent Form F1J-US-HMCB Duloxetine Once-Daily Dosing Versus Placebo in Patients With Major Depression and PainCompletedNCT00036335Phase 3
- Duloxetine Versus Placebo in the Prevention of Relapse of Major Depressive DisorderCompletedNCT00036309Phase 3
- Medroxyprogesterone Compared With Venlafaxine in Treating Hot Flashes in WomenCompletedNCT00030914Phase 3
- Treatment of SSRI-Resistant Depression In Adolescents (TORDIA)CompletedNCT00018902Phase 2/3